Omega Healthcare Investors (OHI) Tops Q4 EPS by 6c, provides guidance
Omega Healthcare Investors (NYSE: OHI) reported Q4 EPS of $0.55, $0.06 better than the analyst estimate of $0.49. Revenue for the quarter came in at $319.22 million versus the consensus estimate of $262.2 million.
2026 GUIDANCE
The Company expects its 2026 Adjusted FFO to be between $3.15 and $3.25 per diluted share.
For earnings history and earnings-related data on Omega Healthcare Investors (OHI) click here.
